OCCIDENT
Munich, Bavariaoccident.group
Overview
An owner-managed venture capital investor that finances deep tech start-ups with a focus on spin-offs from scientific research. The firm invests from the seed stage onwards in the life sciences and industrial tech sectors, using its own capital. It has offices in Munich, Germany, and Zug, Switzerland.
Portfolio Companies
18
Website
occident.groupInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Tubulis | Oct 2025 | Series C | Co-investor |
| Lymphatica Medtech SA | Oct 2024 | Series B | Co-investor |
| Hemotune AG | Mar 2024 | Series B Extension | Co-investor |
| Tubulis | Mar 2024 | Series B Extension | Co-investor |
| Altavo | Feb 2024 | Series A | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
